Total pancreatectomy was performed in dogs; an arginine test was conducted at the first, second and third weeks after surgery, and measurement was made of blood glucose, glucagon and insulin on a time-course basis for a comparative study with normal dogs. 1) After total pancreatectomy, glucagon reacting to 30 K antibody decreased once but increased with the lapse of time when no insulin was administered.
Introduction glucagon-like immunoreactivity is in digestive
In Pathophysiology, particularly in tracts. Vranic, Pek and Kawamori3), Matdisturbances of carbohydrate metabolism, suyama and Fo~4), Mashiter and associates 5) hypoglycemic attack is often observed. This is reported that glucagon reacting to a specific caused by both a defect in pancreatic antibody of the pancreas is still present after glucagon, and an insufficiency in glucose total pancreatectomy; further, this glucagon mobilization together with hypophysial increases abnormally unless insulin is adadrenocortical hypofunction arising from a ministered. Polak and associates6), and Sasaki defect of insulin. From the viewpoint of and associates 7) proved by an irapostoperative management, this condition munofluorescent technic that a cell hardly constitutes animportantquestion, distinguishable from cell A--a pancreatic In 1964 Makman and Sutherland 1) suggested glucagon-secreting cell--is present in the that glucagon, a hyperglycemic glycogenolytic fundus of dogs. This information makes it all factor, is present in gastrointestinal mucosa the more certain that glucagon, the other than the pancreas. In 1966 Unger and hyperglycemic glycogenolytic factor, is present Eisentraut 2) showed by radioimmunoassay that in places other than the pancreas. Regarding diabetes developing after total pancreatectomy, Unger a) maintains that it is caused by bihormonal disturbances resulting from a defect in insulin and excessive glucagon.
Clinically, mention is made of unstable fluctuations in blood glucose level and hypoglycemic state. These clinical conditions can be attributed to both an insufficiency of glucose mobilization required to recover form hypoglycemia, and the defect of insuling). This paper discusses an experimental study using dogs. It was conducted to learn the secretory behavior of glucagon, the glycogenolytic factor, in the postoperative course after total pancreatectomy.
Materials and Methods

Preparation of totally depancreatized
dogs. Twelve mongrel dogs weighing 8-15 kg were fasted overnight and intervenously anesthetized with Nembutal 25mg/kg. Total pancreatectomy was simply carried out by first cutting off the pancreatic branches of the pancreaticoduodenal artery and vein, and then carefully isolationg and ligating the main pancreatic duct.
After surgery, the animals were raised on dog food, and from the third postoperative day lente insulin in a daily dose of 0.5 U/kg was administered subcutaneously before breakfast. 2. Arginine test.
Administration of insulin was discontinued on the day before the experiment. A 24 hourfasting was imposed on three normal dogs, postoperative three one-week-survival dogs, postoperative three two-weeks-survival dogs and postoperative three three-weeks-survival dogs.
On the day of the test, 0.5 g/kg of L-arginine was dissolved in physiological saline solution to make 100ml; for 30 minutes this solution was dripped intravenously under anesthesia with Nembutal. To measure the levels of blood glucose, glucagon, and insulin, blood was drawn from the jugular vein before administration and at 5, 10, 20, 30, 40, 50 and 60 minutes. At the same time, blood was drawn from the portal vein to measure the levels of glucagon.
The measure levels of glucagon, in normal and postoperative three one -week-survival dogs, blood was also collected from the leftgastroepiploic vein (GV), pancreaticoduodenal vein (PV) and mesenteric vein (MV) before administration and at 1, 3, 5, 10, 20, 30, 40, 50 and 60 minutes. 3. Measuring levels of blood glucose, glucagon and insulin. Plasma glucose was measured by the OToluidine method. For glucag'on assays, the specimens were collected in heparinized syringes and promptly transferred to chilled tubes containing Trasylol 0.1 ml (500 Units of kallikrein inhibitor) and 1.2rag EDTA per l ml of blood. Plasma was separated immediately after centrifigation of samples at 4~ for 15 minutes, and stored at -20~ until the time of assay.
Glucagon immunoassay was done by the Charcol-dextran method, using Unger's antiserum 30K (purchased from the Diabetes Research Fund., University of Texas Southwestern Medical School at Dallas, Texas).
Insulin assay was done by the Charcoldextran method with the insulin Radioimmunoassay kit. It showed a lowest value of 103-+20pg/ml two hours after surgery, and then tended to increase gradually with 320-143pg/ml at 12 hours and 363+-134pg/ml at 24 houts. The peripheral plasma glucagon level was 98+35pg/ml before surgery; it lowered to 37+28pg/ml at 6 hours, increased to 120_+107pg/ml at 12 hours, and went to l10+_69pg/ml at 24 hours. The insulin level was 9/~u/ml before surgery, and lowered suddenly two hours after surgery to fluctuate at 2pu/ml or below. (Fig. 2) The fasting plasma glucose level was 163_+93 pg/ml before administration. It showed a biphasic increase with 473-+150 pg/ml at 5 minnutes, and 473-+103pg/ml at 30 minutes, following arginine infusion as shown in the figure. The peripheral plasma glucagon level was 50_+4 pg/ml before administration, also showing a biphasic increase with 168-+22 pg/ml at 5 minutes, and 133_+44pg/ml at 30 minutes, following the start of arginine infusion. The insulin level was 10_+3//u/ml before administration, likewise showing a biphasic increase with 32_+12/~u/ml at 5 minutes, and 22_+6/~u/ml at 30 minutes, following arginine infusion. 3. Arginine test in dogs one week after surgery (Fig. 3) The fasting plasma glucose level was 331_+14mg/dl, showing no remarkable changes. Portal plasma glucagon increased sharply from 225+32pg/ml before administration, to 446+130pg/ml at 5 minutes, showing the highest value, 576-+224pg/ml, at 40 minutes following arginine infusion.
Arginine test in normal dogs
Peripheral plasma glucagon also increased from 121+10pg/ml before administration to 240-+120pg/ml at 20 minutes. The insulin ievel was not more than 3/tu/ml. 4. Arginine test in dogs two weeks after surgery (Fig. 4) The fasting plasma glucose level was 326-+58mg/dl, showing no remarkable changes, Portal palsma glucagon increased from 70+37pg/ml before administration to 139+50 pg/ml at 30 minutes following arginine infusion. Peripheral plasma glucagon was 44-+llpg/ml before administration, showing 102_+37 pg/ml, the highest value, at 30 minutes following arginine infusion. Both showed a monophasic increase.
The insulin level was not more than 1 gu/ml. 5. Arginine test in dogs three weeks after surgery ( The fasting plasma glucose level was 381+48mg/dl, showing remarkable changes. Before administration,reactivity to arginine fell off, making the portal and peripheral plasma glucagon levels 24_18pg/ml and 20_+ 13 pg/ml respectively. The insulin level was not more than 1 gu/ml. 6. Comparison of portal plasma glucagon levels following the start of arginine infusion in normal and totally depancreatized dogs 1, 2, and 3 weeks after surgery (Fig. 6) The portal plasma glucagon level showed a biphasic increase in normal dogs. It increased markedly in totally depancreatized dogs 1 week after surgery, a response higher than in normal dogs. Reactivity to arginine fell off in totally depancreatized dogs 3 weeks after surgery. 7. Comparison of peripheral plasma glucagon levels following the start of arginine infusion in normal and totally depancreatized dogs 1, 2, and 3 weeks after surgery (Fig. 7) In normal dogs peripheral and portal plasma glucagon showed biphasic increases with a rate of 1/2 to 1/3.
In totally depancreatized dogs 1 to 2 weeks after surgery, there was a monophasic increase, the level being about 1/2 that of portal plasma glucagon. In totally depancreatized dogs three weeks after surgery, the levels of both peripheral and portal plasma glucagon were almost the same. The reactivity fell off. 8. Glucagon levels in left-gastroepiploic vein (GV), pancreaticoduodenal vein (PV) and mesenteric vein (MV) in normal dogs and totally depancreatized dogs one week after surgery (Fig. 8 ) In normal dogs basal mean glucagon level was 228pg/ml on PV, 180pg/ml on GV, and 151 pg/ml on MV; when arginine was infused, the glucagon level increased markedly in PV, with PV 537pg/ml, GV 313pg/ml, and MV 183 pg/ml at 3 minutes.
In totally depancreatized dogs one week after surgery, basal mean glucagon level stood at PV 210 pg/ml, GV 503 pg/ml and MV 243 pg/ml; when arginine was infused there was observed a marked increase in GV, with PV 292pg/ml; GV 970pg/ml and MV 235pg/ml at 3 minutes.
From the results above, it was assumed that glucagon increase in portal blood is caused mainly by glucagon from PV in normal dogs, and also by a glucagon increase of GV and part of MV in totally depancreatized dogs.
Discussion
There is a defect of the exocrine and endorcrine function of the pancreas. Thus total pancreatectomy brings on a great variety of pathologic states after surgery. Among these states, disturbances in carbohydrate metabolism is the most important problem in terms of postoperative management after total pancreatectomy.
Recently,
Unger H) and Fo~ 12) have developed a specific antibody for pancreatic glucagon. Thus it has been possible to observe a difference not only in insulin level but also in glucagon level between normal persons and diabeticsl~.~4). It is said that diabetics have relative hyperglucagonemia. Parrilla 15) and Unger 16) hold that blood glucose level is influenced by the levels of portal blood insulin and glucagon, and they stress the role of glucagon in diabetics. Recently it has been reported that, in totally depancreatized dogs glucagon reacting to a specific antibody of pancreatic glucagon increases abnormally unless insulin treatment is done. Meanwhile, for these dogs, it is known by the insulin sensitivity test that insulin half life is prolonged five weeks or more after total pancreatectomy as compared with normal dogs'7). Administration of insulin suppresses glucagon secreted from the fundus thus it is assumed to cause lowered activity in recovering from hypoglycemia18). In this present experiment, portal and peripheral blood glucagon fell off once, and then increased when insulin was not ad-ministered after total pancreatectomy, as shown in Fig. 1 . This indicates that glucagon reacting to 30K antibody is secreted from other organs. In dogs one week after total pancreatectomy, the glucagon secretory reaction to arginine is higher than that in normal dogs, as shown in Fig. 3 . This is considered to have something to do with surgical invasion stress 19,2o) deficiency of insulin after operation. 
